Skip to main content Skip to footer

Life Science Market Report | Q1 2021

Download Report
alt=""

Interest Flocks to Life Sciences as Vaccines Heighten Sector Focus

From public and private funding increases to the demand created by the COVID-19 pandemic and the vaccine rollout underway to combat it, the life sciences sector is seeing a significant increase in interest from both developers and investors. In addition, rapid growth in Advanced Therapy Medicinal Products (ATMP) science, which includes gene therapy, is driving demand for lab and manufacturing space from both early and mid-stage biotech companies.

All-important leasing data points, such as vacancy and net absorption, also compare favorably to the challenged office market, suggesting even more positive days could be ahead for the sector. In this report, we will analyze the factors contributing to these trends and take a closer look at 12 leading and emerging life science clusters across the U.S., each of which are examined in turn.

View related videos: 

View Steig Seaward Video       View Mike Brown Video

Infographic: 

Download Infographic

alt=""

Life Science Market Report | Q1 2021

Download Report
Related Experts

Michael Brown

Senior Director, Office Services

Jacksonville

As the National Leader of Colliers Global Life Science Practice Group, I bring 43 years of commercial real estate experience and 22 years of experience focusing on life science real estate. My acquired knowledge in life science work has been on both the landlord (Wexford Science & Technology) and the tenant side within the industry.

I have experience with Advanced Therapeutic Medicinal Products, Parenteral Fill Finish, Solid Oral Dosage, Biologics, and Medical Device manufacturing facilities, as well as a solid background in Laboratory Research and Development/Pilot scale facilities and controlled environments. Through my work on local, regional and national site selection assignments, I have developed a firm grasp of the rigorous process required to meet the key search criteria of my clients.  

My knowledge of market conditions and influences in the life sciences supports my ability to be creative in structuring the financial details of both lease and purchase transactions. My network of a wide variety of trusted advisors within the industry facilitates a regular flow of information about life science real estate trends, pricing, and comparable data for leasing and sales transactions.

View expert

Steig Seaward

National Director of Research

Los Angeles - El Segundo

Steig Seaward is the national director of research and oversees the research and GIS teams for the United States. A proven CRE tech leader, Steig brings 25+ years of experience providing research and analysis, product design and customer retention strategies across the information technology and commercial real estate industries.   

Prior to joining Colliers,  Steig spent nine years as the senior research director overseeing research and marketing operations for the east coast region of Grubb & Ellis and more recently was the EVP of Customer Success at Xceligent, a full service-SAAS based commercial real estate information provider.  Steig also served as the national director of Business Development and Client Services during his 13-year career at Xceligent.  In addition, Steig also gained valuable experience as the director of sales for IdealSpot, a demographic and site selection software provider, VP of Technology & Member Services for the Denver Metropolitan Commercial Association of Realtors and began his career as a research analyst for the Resolution Trust Corporation.

Areas of expertise include:

·       Commercial Real Estate Research & Analysis

·       Customer Facing Solution Sales

·       Product Design & Implementation

·       Customer & Employee Curriculum Development and Training

·       SAAS/Subscription-Based Services

·       Customer Success Development

View expert